| ID | 116349 |
| 著者 |
板東, 浩
Tokushima University|Japan Low Carbohydrate Diet Promotion Association|Sakamoto Hospital
KAKEN研究者をさがす
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
| キーワード | Xultophy
Insulin Degludec and Liraglutide
Type 2 Diabetes Mellitus
Meal Tolerance Test
Postprandial Hyperglycemia
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | The case is a 69-year-old male patient with Type 2 Diabetes Mellitus （T2DM） for 21 years. His diabetic control was not so satisfactory, and his HbA1c value increased in spring 2021. Then, he started Xultophy (IDegLira), which includes a fixed ratio of two agents of basal degludec and liraglutide. Just after providing Xultophy, the daily profile of blood glucose decreased from 179-400 mg/dL to 112-171 mg/dL, with remarkable clinical efficacy. He usually takes 80g of carbohydrates in breakfast, and the meal tolerance test (MTT) was challenged. As carbohydrate loading was given 100-75-50-0%, postprandial hyperglycemia at 60-min showed 277-219-159-133 mg/dL, respectively.
|
| 掲載誌名 |
Asploro Journal of Biomedical and Clinical Case Reports
|
| ISSN | 25820370
|
| 出版者 | Asploro
|
| 巻 | 4
|
| 号 | 2
|
| 開始ページ | 145
|
| 終了ページ | 152
|
| 発行日 | 2021-08-12
|
| 権利情報 | This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
